Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015024
Filing Date
2023-06-08
Accepted
2023-06-08 21:50:24
Documents
1
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12501
  Complete submission text file 0000899243-23-015024.txt   13862
Mailing Address C/O ICAD INC 98 SPIT BROOK ROAD SUITE 100 NASHUA NH 03062
Business Address
Subramaniam Somu (Reporting) CIK: 0001508910 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 231003711

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations